|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 9/48 | (2006.01) |
| A61K | (2006.01) | ||
| A61K 31/216 | (2006.01) | ||
| A61K 31/277 | (2006.01) | ||
| A61K 31/352 | (2006.01) | ||
| A61K 31/4178 | (2006.01) | ||
| A61K 31/4422 | (2006.01) | ||
| A61K 31/49 | (2006.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/554 | (2006.01) | ||
| A61K 31/704 | (2006.01) | ||
| A61K 45/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 1185274 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00901264.2 |
| Date of filing the European patent application | 2000-02-01 | |
| (97) | Date of publication of the European application | 2002-03-13 |
| (45) | Date of publication and mention of the grant of the patent | 2004-11-17 |
| (46) | Date of publication of the claims translation | 2005-03-25 |
| (86) | Number | PCT/GB2000/000278 |
| Date | 2000-02-01 |
| (87) | Number | WO 2000/045817 |
| Date | 2000-08-10 |
| (30) | Number | Date | Country code |
| 9902593 | 1999-02-06 | GB | |
| 9921063 | 1999-09-08 | GB | |
| 9921064 | 1999-09-08 | GB |
| (72) |
RAZA, Ali, US
PEARS, John Stuart, GB
HUTCHINSON, Howard Gerard, US
SCHNECK, Dennis, US
BABA, Takahiko, JP
TOUCHI, Akira, JP
YAMAGUCHI, Yoshitaka, JP
|
| (73) |
SHIONOGI & CO., LTD.,
1-8, Doshomachi 3-chome, Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
AstraZeneca AB, 151 85 Södertälje, SE |
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Vaistų deriniai, turintys (E)-7-[4-(4-fluorfenil)-6-izopropil-2-[metil(metilsulfonil)amino]-pirimidin-5-ilo] (3R,5S)-3,5-dihidroksihept-6-enoinės rūgšties ir slopintojo, stimuliatoriaus arba P450 izofermento 3A4 substrato |
| DRUG COMBINATIONS COMPRISING (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]PYRIMIDIN-5-YL](3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND AN INHIBITOR, INDUCER OR SUBSTRATE OF P450 ISOENZYME 3A4 |
| Payment date | Validity (years) | Amount | |
| 2019-01-28 | 20 | 347.00 EUR |